A type of modified-release dosage form. A descriptive term for a dosage form deliberately modified to delay release of the API for some period of time after initial administration. For example, release of the API is prevented in the gastric environment but promoted in the intestinal environment; in this sense, the term is synonymous with Enteric-Coated or Gastro-Resistant.
Glossary
Delayed Release
03.28.12
-
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Breaking News | Facilities | Industry News
Paratek Opens New Office in King of Prussia
Novel antibiotic developer expands presence in Philadelphia region with 19,000 square-foot office space
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Recipharm Extends Partnership with Sato Pharmaceutical
The CDMO will manufacture Emla Patch for the Japanese market
-
Drug Development | Industry News
Paratek Expands PA Site
Will support development and registration activities to support the company's potential NDA
